Benzinga's Microcap Movers for Wednesday March 14, 2012

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

Shares of FACT Corporation (FCTOA), the Calgary, Canada developer, licensor, and supplier of functional bake mixes to manufacturers of bakery and pasta products, rose 178% Wednesday on 800,000 shares. FACT has traded rarely, the last time on February 23. FACT Corporation announced Saturday that it has plans to initiate an Investor Relations program. This program will be structured to update shareholders on current and future planned activities, to bring awareness to our 2012 initiatives, and to undertake a series of meetings with financial industry representatives in Europe, as well as certain East and West Coast American cities. These meetings are expected to involve: investment bankers, broker-dealers, financial publications, independent financial journalists, research analysts, investment advisers, fund managers, financial communications channels and related organizations. The goal of the program will be to expand our corporate visibility and open communications with the investment community. In addition the Company will seek to raise expansion capital working with select firms that have expressed initial interest in helping the Company bring its previously announced 2011 and 2012 initiatives to fruition. FACT Corporation closed at $0.14 on Wednesday.

Shares of NeurogesX

, the San Mateo, CA biopharmaceutical company, rose 28% Wednesday on almost 3 times the average daily volume. Wedbush upgraded NeurogesX from Neutral to Outperform Wednesday, with a $2 PT. NeurogesX closed at $0.62 on Wednesday.

Shares of NuPathe

, the Conshohocken, PA specialty pharmaceutical company, rose 21% Wednesday on 9 times the average daily volume. A positive

article Wednesday said NuPathe could double. NuPathe closed at $3.97 on Wednesday.